HemAware

Featured On HemAware

Why Women and Girls with Bleeding Disorders Have Been Overlooked

Too often, heavy bleeding is dismissed as “normal.” Now, women with bleeding disorders and providers in the community are speaking up — and changing how care is understood.

Read Now

Why Women and Girls with Bleeding Disorders Have Been Overlooked
2026 Bleeding Disorders Conference Preview

Here’s a sampling of the sessions you can look forward to at BDC.
Read More

2026 Bleeding Disorders Conference Preview
Congenital Fibrinogen Deficiency Symptoms, Types, and Treatment

We answer some of the most common questions about this rare bleeding disorder.
Read More

Congenital Fibrinogen Deficiency Symptoms, Types, and Treatment

Recent Articles

NBDF’s President and CEO on the State of the Bleeding Disorders Community

Phil Gattone, NBDF’s president and CEO, reflects on passion, organizational growth, and the future of bleeding disorders care.

NBDF in Action

Two advocates, pose with an older man in a suit and tie inside a legislative office decorated with flags and framed photos, during a Washington Days advocacy visit.

Fighting for Better Care for Women with Bleeding Disorders

At Washington Days 2026, South Carolina advocate Candi Mitchum helped bring a powerful message to Capitol Hill.

Advocacy

A family of four wearing helmets rides bicycles together on a wooded trail, smiling and enjoying an active outing.

Summer Heat and Bleeding Disorders: Staying Safe During an Active Season

Here’s what you need to know about outdoor activities, treatment routines, and medications when temperatures rise.

Taking Charge, Family Matters

Record Turnout

The National Hemophilia Foundation’s (NHF’s) Annual Meeting brings together people with bleeding disorders and their families, providers and industry representatives...

NBDF in Action, NBDF in Action

Acetaminophen Caution

Acetaminophen is a time-tested pain reliever that many people reach for when headaches or muscle and joint pain become unbearable...

Pain Management

FDA Approves New HIV Drug

When the US Food and Drug Administration (FDA) approved Tivicay ® (dolutegravir), a new drug to treat HIV, in August...

Research & Treatment, HIV

The Value of Genetic Counseling

Adenine, thymine, cytosine and guanine—these are the simple, yet complex building blocks of our DNA. To most, these words seem...

Family Matters

Need Information about Bleeding Disorders?

Contact The Neil Frick Resource Center (NFRC)

Contact NFRC

HemAware

Featured On HemAware

Why Women and Girls with Bleeding Disorders Have Been Overlooked

Recent Articles